Alzheimer Disease: Diffusion Tensor MRI and a...

Dr. Ashwin Singh Parihar sits down with to discuss how post-therapy Lutetium 177 PSMA SPECT CT may help predict overall survival in patients with metastatic castration resistant prostate cancer and shape future treatment decisions. Drawing from the ENZAPI trial, they explore quan ...  Show more

Dr. Siddhant Dogra sits down with Dr. Su Hwan Kim to discuss how reader experience influences the performance and real world utility of large language models for brain MRI differential diagnosis. Together they explore AI assisted decision making, automation bias, radiology traini ...  Show more

In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.

<stron ...

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ...  Show more

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article in Nature. Disclosures can be foun ...  Show more

This episode is a conversation with Drs. Clifford Jack and Kevin Duff about recent updates to the diagnosis and staging of Alzheimer's disease (AD). We discuss biological versus clinical/pathological approaches to diagnosing AD, analogies between AD and other ...